These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 31965968)

  • 21. Botulinum toxins in the treatment of primary focal dystonias.
    Truong D
    J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic Lesioning of the Thalamic Vo Nucleus for the Treatment of Writer's Cramp (Focal Hand Dystonia).
    Shimizu T; Maruo T; Miura S; Kishima H; Ushio Y; Goto S
    Front Neurol; 2018; 9():1008. PubMed ID: 30534112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic Non-task-Specific Upper Limb Dystonia, a Neglected Form of Dystonia.
    Defazio G; Ercoli T; Erro R; Pellicciari R; Mascia MM; Fabbrini G; Albanese A; Lalli S; Eleopra R; Barone P; Marchese R; Ceravolo R; Scaglione C; Liguori R; Esposito M; Bentivoglio AR; Bertolasi L; Altavista MC; Bono F; Pisani A; Girlanda P; Berardelli A;
    Mov Disord; 2020 Nov; 35(11):2038-2045. PubMed ID: 32662572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensory trick in upper limb dystonia.
    Dagostino S; Ercoli T; Gigante AF; Pellicciari R; Fadda L; Defazio G
    Parkinsonism Relat Disord; 2019 Jun; 63():221-223. PubMed ID: 30655163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin in the treatment of writer's cramp: a double-blind study.
    Tsui JK; Bhatt M; Calne S; Calne DB
    Neurology; 1993 Jan; 43(1):183-5. PubMed ID: 8423882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin in writer's cramp: objective response evaluation in 31 patients.
    Wissel J; Kabus C; Wenzel R; Klepsch S; Schwarz U; Nebe A; Schelosky L; Scholz U; Poewe W
    J Neurol Neurosurg Psychiatry; 1996 Aug; 61(2):172-5. PubMed ID: 8708685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin for motor disorders.
    Safarpour D; Jabbari B
    Handb Clin Neurol; 2023; 196():539-555. PubMed ID: 37620089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Signature of Primary Writing Tremor Is Dystonic.
    Latorre A; Rocchi L; Batla A; Berardelli A; Rothwell JC; Bhatia KP
    Mov Disord; 2021 Jul; 36(7):1715-1720. PubMed ID: 33786886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of upper limb dystonia with botulinum toxin.
    Hayes MW; Yiannikas C
    J Clin Neurosci; 1996 Apr; 3(2):124-8. PubMed ID: 18638853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary Writing Tremor.
    Vives-Rodriguez A; Kim CY; Louis ED
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():586. PubMed ID: 30402337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin in clinical practice.
    Hughes AJ
    Drugs; 1994 Dec; 48(6):888-93. PubMed ID: 7533696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL; Greene P; Fahn S; Pedersen SF
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Writer's cramp: the experience with botulinum toxin injections in 25 patients.
    Poungvarin N
    J Med Assoc Thai; 1991 May; 74(5):239-47. PubMed ID: 1783871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.
    Yoshida K
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the Use of Botulinum Toxin Therapy for Focal and Task-Specific Dystonias.
    Lungu C; Ahmad OF
    Semin Neurol; 2016 Feb; 36(1):41-6. PubMed ID: 26866495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease-oriented approach to botulinum toxin use.
    Jankovic J
    Toxicon; 2009 Oct; 54(5):614-23. PubMed ID: 19073203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind trial of botulinum toxin for treatment of focal hand dystonia.
    Cole R; Hallett M; Cohen LG
    Mov Disord; 1995 Jul; 10(4):466-71. PubMed ID: 7565828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
    Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
    Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal task specific dystonia: a review and update.
    Stahl CM; Frucht SJ
    J Neurol; 2017 Jul; 264(7):1536-1541. PubMed ID: 28039522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.